DCK and acute lymphoblastic leukemia: Higher DCK expression was associated with higher Ara‐C sensitivity, and the knockout of DCK expression by a genome editing procedure using a CRISPR‐Cas9 system 14, 15 in an Ara‐C‐sensitive‐ALL cell line induced resistance to Ara‐C.